Total Payments
$9,430
2024 Payments
$1,684
Companies
35
Transactions
266
Medicare Patients
18,930
Medicare Billing
$2.8M
Payment Breakdown by Category
Food & Beverage$5,040 (53.4%)
Other$3,000 (31.8%)
Education$1,110 (11.8%)
Travel$280.61 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,040 | 248 | 53.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,000 | 3 | 31.8% |
| Education | $1,110 | 14 | 11.8% |
| Travel and Lodging | $280.61 | 1 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $3,057 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $1,579 | 60 | $0 (2024) |
| Teleflex LLC | $909.20 | 14 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $571.04 | 35 | $0 (2024) |
| NeoTract Inc. | $416.56 | 28 | $0 (2020) |
| Janssen Biotech, Inc. | $309.74 | 11 | $0 (2024) |
| Boston Scientific Corporation | $287.34 | 13 | $0 (2023) |
| Myovant Sciences Inc. | $271.89 | 13 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $220.16 | 10 | $0 (2024) |
| ABBVIE INC. | $188.30 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,684 | 41 | Teleflex LLC ($732.20) |
| 2023 | $971.56 | 43 | BIOTISSUE HOLDINGS, INC. ($167.71) |
| 2022 | $552.99 | 26 | Teleflex LLC ($130.49) |
| 2021 | $811.46 | 35 | Astellas Pharma US Inc ($416.47) |
| 2020 | $236.51 | 10 | Janssen Biotech, Inc. ($79.99) |
| 2019 | $3,849 | 45 | Intuitive Surgical, Inc. ($3,000) |
| 2018 | $734.13 | 38 | Astellas Pharma US Inc ($237.47) |
| 2017 | $590.43 | 28 | Astellas Pharma US Inc ($227.06) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Urology Gynecology | ||||||
| 12/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: UROLOGY | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $0.87 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Oncology | ||||||
| 11/14/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $44.64 | General |
| Category: SURGERY | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $78.99 | General |
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 10/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: UROLOGY | ||||||
| 10/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 09/16/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Oncology | ||||||
| 09/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: Oncology | ||||||
| 09/05/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: UROLOGY | ||||||
| 07/31/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 07/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Oncology | ||||||
| 07/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $2.20 | General |
| Category: Oncology | ||||||
| 06/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: Oncology | ||||||
| 05/18/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | Cash or cash equivalent | $188.62 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 05/17/2024 | Teleflex LLC | UROLIFT (Device) | Travel and Lodging | Cash or cash equivalent | $280.61 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 5,307 | 13,125 | $3.1M | $668,974 |
| 2022 | 28 | 4,849 | 11,431 | $3.0M | $729,901 |
| 2021 | 29 | 4,166 | 9,872 | $2.7M | $692,052 |
| 2020 | 28 | 4,608 | 10,274 | $2.4M | $667,779 |
Total Patients
18,930
Total Services
44,702
Medicare Billing
$2.8M
Procedure Codes
116
All Medicare Procedures & Services
116 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 885 | 3,426 | $524,041 | $232,685 | 44.4% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 189 | 189 | $127,613 | $57,051 | 44.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 234 | 248 | $107,448 | $48,959 | 45.6% |
| 64566 | Insertion of lower leg neurostimulator electrode | Office | 2023 | 76 | 508 | $139,527 | $46,923 | 33.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 335 | 508 | $53,388 | $37,220 | 69.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 272 | 359 | $80,825 | $35,701 | 44.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 48 | 263 | $210,400 | $34,418 | 16.4% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 30 | 57 | $239,400 | $23,229 | 9.7% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Facility | 2023 | 87 | 546 | $703,600 | $21,478 | 3.1% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Facility | 2023 | 87 | 100 | $177,800 | $15,994 | 9.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 179 | 179 | $40,365 | $15,477 | 38.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 277 | 428 | $42,800 | $14,748 | 34.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 103 | 104 | $27,310 | $11,727 | 42.9% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 757 | 2,651 | $31,812 | $10,382 | 32.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 517 | 1,107 | $110,700 | $9,532 | 8.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 48 | 263 | $18,200 | $7,273 | 40.0% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 39 | 50 | $185,866 | $7,022 | 3.8% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 190 | 190 | $78,124 | $5,021 | 6.4% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 37 | 102 | $15,351 | $5,020 | 32.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 443 | $23,957 | $4,852 | 20.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 32 | $13,393 | $4,374 | 32.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 430 | 499 | $49,900 | $4,314 | 8.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 35 | 72 | $5,846 | $2,831 | 48.4% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 15 | 15 | $6,913 | $2,744 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,868 | $2,577 | 37.5% |
About Dr. Theodore Affue, M.D
Dr. Theodore Affue, M.D is a Urology healthcare provider based in El Centro, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386674000.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Theodore Affue, M.D has received a total of $9,430 in payments from pharmaceutical and medical device companies, with $1,684 received in 2024. These payments were reported across 266 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,040).
As a Medicare-enrolled provider, Affue has provided services to 18,930 Medicare beneficiaries, totaling 44,702 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 116 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location El Centro, CA
- Active Since 07/05/2006
- Last Updated 05/04/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386674000
Products in Payments
- Da Vinci Surgical System (Device) $3,057
- UROLIFT (Device) $778.71
- Nubeqa (Drug) $540.05
- XTANDI (Drug) $432.23
- UroLift (Device) $405.56
- ORGOVYX (Drug) $312.88
- ERLEADA (Drug) $284.91
- XIAFLEX (Biological) $236.23
- NEOX (Medical Supply) $167.71
- GEMTESA (Drug) $153.44
- PROVENGE (Drug) $142.11
- Lupron (Drug) $135.85
- UroLift System (Device) $130.49
- Xtandi (Drug) $127.60
- Myrbetriq (Drug) $112.41
- LifeVest (Device) $100.00
- Holmium Lasers & Accessories (Device) $94.68
- TITAN (Device) $94.18
- WATCHMAN (Device) $92.60
- Axonics (Device) $64.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.